Progressive Pulmonary Fibrosis: Clinical Trials

1 trial for Progressive Pulmonary Fibrosis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow Progressive Pulmonary Fibrosis: new trials by email Literature Review of Progressive Pulmonary Fibrosis trials Research Report on Progressive Pulmonary Fibrosis

Trials (filtered) newest first · largest first

All 1 trial

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
AP01 - Progressive Pulmonary Fibrosis, Idiopathic Pulmonary Fibrosis (IPF)
Phase 2RecruitingAvalyn Pharma Inc.3402025-04-172026-11-05

Narrower conditions

Idiopathic Pulmonary Fibrosis (1)

Broader conditions

Lung Diseases (1)  ·  Lung Diseases, Interstitial (1)  ·  Pulmonary Fibrosis (1)  ·  Respiratory Tract Diseases (1)

Sponsors

Avalyn Pharma Inc. (1)

Countries

Argentina (1)  ·  Australia (1)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Italy (1)  ·  Netherlands (1)  ·  New Zealand (1)  ·  Poland (1)  ·  Spain (1)  ·  United Kingdom (1)  ·  United States (1)